Jelmer Visser interprets for Innovation Origins the spread of the corona pandemic in Europe. This week: Where are countries one month after V Day?
A group of international scientists has identified an enzyme activity essential for coronavirus replication as a potential focus for new therapeutic approaches.
For Innovation Origins, Jelmer Visser clarifies the corona pandemic in Europe This week: What are the experiences with curfews and is the Netherlands starting to catch up on its vaccine backlog?
ML6, a Belgian company specializing in artificial intelligence and machine learning, is launching an application that can tell when someone is not wearing a face mask.
Researchers at the University of Bonn, Germany, together with international colleagues, have found and further developed novel antibody fragments, so-called "nanobodies", against the SARS-CoV-2 virus.
Thanks to this new tool developed by Swedish researchers, the number of corona patient hospitalizations can be predicted three weeks in advance.
Nijmegen-based biotech company is dependent on capital from venture investors and receives little extra money from the government for Corona research
British researchers have identified in a study five genes associated with the most severe form of COVID-19.
A team of researchers from Munich University of Applied Sciences has examined to what extent transparent face shields are suitable for protection against infection with the coronavirus.
Leading covid research shows whether someone has Corona, based on a CT scan or X-ray photo
Jelmer Visser explains the movements of the corona pandemic in Europe for Innovation Origins. This week: Is there really light at the end of the tunnel?
German and British scientists have discovered that the protease inhibitor aprotinin can prevent the SARS CoV-2 virus from entering host cells.
AstraZeneca and Moderna have presented the interim results of their Phase 3 research. After a long wait, there are now three vaccines in sight instead of one.
Austrian researchers have shown in a study that natural UV radiation in winter is too weak to destroy SARS-CoV-2 viruses in aerosols and on surfaces.
Signify will install 15 Philips UV-C disinfection upper air luminaires
In cooperation with the Frankfurt Institute for Advanced Studies (FIAS), Forschungszentrum Jülich has calculated several possible scenarios for the further course of the corona pandemic in Germany.
Researchers at the University of Augsburg in Germany are working on an app that can detect an infection with the SARS CoV-2 coronavirus via speech. The app currently has an accuracy rate of over 80%.
The vaccine from Pfizer and BioNTech is 90 percent effective. Today, the companies announced the preliminary results of their phase three trials.
British researchers have observed robust T-cell responses to SARS CoV-2 virus peptides in the majority of adults even six months after an asymptomatic or mild COVID-19 infection.
Researchers have successfully tested an air filtration system that can remove 90% of aerosols from the air in classrooms.